Tirzepatide 10mg
Dual GLP-1/GIP receptor agonist — up to 22.5% body weight reduction in trials, the most effective approved weight loss compound to date.
Out of Stock
SKU: ML-TIRZ-10MG
💰 Volume Discounts:
Buy 3+ vials = 10% off · Buy 5+ vials = 15% off
Tirzepatide (brand names Mounjaro and Zepbound) is a dual GIP and GLP-1 receptor agonist developed by Eli Lilly. By targeting both the GIP receptor (which regulates fat storage and insulin sensitivity) and the GLP-1 receptor, Tirzepatide produces weight loss results that exceed any single-receptor GLP-1 agonist. The SURMOUNT-1 trial showed average weight loss of 22.5% at the highest dose over 72 weeks — comparing favourably to bariatric surgery outcomes. It is FDA-approved for obesity (Zepbound) and type 2 diabetes (Mounjaro).
Related Products
AOD9604 5mg
Growth hormone fragment for targeted fat reduction — stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or growth.
FeaturedRetatrutide (RT3-GLP) 10mg
Triple receptor agonist studied in clinical research on GLP-1, GIP, and glucagon pathway modulation.
Retatrutide (RT3-GLP) 20mg
Triple receptor agonist (GLP-1/GIP/glucagon) — 20mg vial offers a lower cost per mg than the 10mg vial.
MOTS-C 40mg
Mitochondrial exercise mimetic — AMPK activation, insulin sensitivity, and fat metabolism. Larger dose vial for extended protocols.
Community
See all →AOD9604 vs Tirzepatide for fat loss — different mechanisms?
I'm trying to understand the difference between AOD9604 and GLP-1 agonists like Tirzepatide for fat loss. From my research: - AOD9604 = fragment of human growth hormone, targets fat cells directly - Tirzepatide = GLP-1/GIP agonist, works through appetite suppression and insulin So they work completely differently? Could you theoretically stack them? I'm leaning towards AOD9604 because I don't want appetite suppression — I actually enjoy eating and I'm quite active. I just have stubborn lower belly fat that won't budge. Anyone used AOD9604 on its own for targeted fat loss? Results?
Retatrutide vs Tirzepatide — which is better for weight management?
I see Mito Labs has both Tirzepatide and Retatrutide now. From what I understand: - Tirzepatide = dual agonist (GIP + GLP-1) - Retatrutide = triple agonist (GIP + GLP-1 + Glucagon) So Retatrutide is the "newer generation" version? The triple mechanism apparently targets fat loss more aggressively but I'm worried it might be too strong or have worse side effects. Has anyone tried both? Or switched from Tirzepatide to Retatrutide? What was the difference like? Also curious about dosing — do you start lower with Retatrutide since it's more potent?
Tirzepatide 12 week update — down 9kg with minimal muscle loss
I started Tirzepatide about 3 months ago at 85kg. I'm 168cm so that put me at a BMI of about 30. I was eating well and doing Pilates 5x/week but couldn't seem to drop below 83kg no matter what. **Protocol:** - Weeks 1-4: 2.5mg/week (10mg vial) - Weeks 5-8: 5mg/week - Weeks 9-12: 7.5mg/week (moved to 20mg vial — way better value) **Results:** - SW: 85kg → CW: 76kg (−9kg) - Lost about 2 inches off waist - DEXA scan shows minimal muscle loss (−0.8kg lean mass vs −8.2kg fat) - Blood sugar and cholesterol both improved **Side effects:** - Weeks 1-3: mild nausea for a few hours after injection, eating small meals helped - Reduced appetite (this is the main mechanism — you just don't feel as hungry) - Slightly slower digestion **Tips:** - Start low and titrate slowly, seriously - Pin in the evening before bed to sleep through any nausea - Keep protein high (I aimed for 120g/day) to preserve muscle - The 20mg vial is significantly better value if you know you'll continue Very happy with the results. Planning to maintain at 5mg/week for a few more months then taper off.